438 related articles for article (PubMed ID: 18677409)
21. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.
Bowles NP; Karatsoreos IN; Li X; Vemuri VK; Wood JA; Li Z; Tamashiro KL; Schwartz GJ; Makriyannis AM; Kunos G; Hillard CJ; McEwen BS; Hill MN
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):285-90. PubMed ID: 25535367
[TBL] [Abstract][Full Text] [Related]
22. Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor.
Yoshino S; Satoh T; Yamada M; Hashimoto K; Tomaru T; Katano-Toki A; Kakizaki S; Okada S; Shimizu H; Ozawa A; Tuchiya T; Ikota H; Nakazato Y; Mori M; Matozaki T; Sasaki T; Kitamura T; Mori M
Endocrinology; 2014 Sep; 155(9):3459-72. PubMed ID: 25004093
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
[TBL] [Abstract][Full Text] [Related]
24. The role of the endocannabinoid system in the control of energy homeostasis.
Osei-Hyiaman D; Harvey-White J; Bátkai S; Kunos G
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S33-8. PubMed ID: 16570103
[TBL] [Abstract][Full Text] [Related]
25. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
Pang Z; Wu NN; Zhao W; Chain DC; Schaffer E; Zhang X; Yamdagni P; Palejwala VA; Fan C; Favara SG; Dressler HM; Economides KD; Weinstock D; Cavallo JS; Naimi S; Galzin AM; Guillot E; Pruniaux MP; Tocci MJ; Polites HG
Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481
[TBL] [Abstract][Full Text] [Related]
26. Beneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice.
Tang Y; Ho G; Li Y; Hall MA; Hills RL; Black SC; Liang Y; Demarest KT
PLoS One; 2012; 7(8):e42134. PubMed ID: 22870290
[TBL] [Abstract][Full Text] [Related]
27. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
[TBL] [Abstract][Full Text] [Related]
28. Partial leptin deficiency confers resistance to diet-induced obesity in mice.
Zhao S; Li N; Zhu Y; Straub L; Zhang Z; Wang MY; Zhu Q; Kusminski CM; Elmquist JK; Scherer PE
Mol Metab; 2020 Jul; 37():100995. PubMed ID: 32289482
[TBL] [Abstract][Full Text] [Related]
29. Decreasing CB
Jourdan T; Nicoloro SM; Zhou Z; Shen Y; Liu J; Coffey NJ; Cinar R; Godlewski G; Gao B; Aouadi M; Czech MP; Kunos G
Mol Metab; 2017 Nov; 6(11):1517-1528. PubMed ID: 29107297
[TBL] [Abstract][Full Text] [Related]
30. Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice.
Yu XX; Watts LM; Manchem VP; Chakravarty K; Monia BP; McCaleb ML; Bhanot S
PLoS One; 2013; 8(7):e66923. PubMed ID: 23922646
[TBL] [Abstract][Full Text] [Related]
31. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
33. Adipose tissue transplantation ameliorates lipodystrophy-associated metabolic disorders in seipin-deficient mice.
Wang H; Xu PF; Li JY; Liu XJ; Wu XY; Xu F; Xie BC; Huang XM; Zhou ZH; Kayoumu A; Liu G; Huang W
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E54-E62. PubMed ID: 30457912
[TBL] [Abstract][Full Text] [Related]
34. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
35. Adropin deficiency is associated with increased adiposity and insulin resistance.
Ganesh Kumar K; Zhang J; Gao S; Rossi J; McGuinness OP; Halem HH; Culler MD; Mynatt RL; Butler AA
Obesity (Silver Spring); 2012 Jul; 20(7):1394-402. PubMed ID: 22318315
[TBL] [Abstract][Full Text] [Related]
36. Trans-Fatty Acids Aggravate Obesity, Insulin Resistance and Hepatic Steatosis in C57BL/6 Mice, Possibly by Suppressing the IRS1 Dependent Pathway.
Zhao X; Shen C; Zhu H; Wang C; Liu X; Sun X; Han S; Wang P; Dong Z; Ma X; Hu K; Sun A; Ge J
Molecules; 2016 May; 21(6):. PubMed ID: 27248994
[TBL] [Abstract][Full Text] [Related]
37. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
[TBL] [Abstract][Full Text] [Related]
38. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.
Deveaux V; Cadoudal T; Ichigotani Y; Teixeira-Clerc F; Louvet A; Manin S; Nhieu JT; Belot MP; Zimmer A; Even P; Cani PD; Knauf C; Burcelin R; Bertola A; Le Marchand-Brustel Y; Gual P; Mallat A; Lotersztajn S
PLoS One; 2009 Jun; 4(6):e5844. PubMed ID: 19513120
[TBL] [Abstract][Full Text] [Related]
40. ErbB4 deletion predisposes to development of metabolic syndrome in mice.
Zeng F; Wang Y; Kloepfer LA; Wang S; Harris RC
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E583-E593. PubMed ID: 29944391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
